# Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19

> **NCT04344080** · NA · COMPLETED · sponsor: **Universitätsklinikum Hamburg-Eppendorf** · enrollment: 24 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** CytoSorb-Therapy

## Key facts

- **NCT ID:** NCT04344080
- **Lead sponsor:** Universitätsklinikum Hamburg-Eppendorf
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-01
- **Primary completion:** 2021-04-10
- **Final completion:** 2021-04-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2022-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04344080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04344080, "Effect of CytoSorb Adsorber on Hemodynamic and Immunological Parameters in Critical Ill Patients With COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04344080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*